Morse, Michael A <br/><br/>
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.  [electronic resource] 

 -  Cancer investigation  Jun 2003 
 - 341-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0735-7907 
<br/><br/><label>Standard No.: </label>10.1081/cnv-120018224  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoembryonic Antigen--adverse effects<br/>Colonic Neoplasms--pathology<br/>Dendritic Cells--physiology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Leukapheresis<br/>Liver Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>RNA, Messenger--genetics<br/>Recombinant Proteins--therapeutic use<br/>Survival Analysis<br/>Transfection--methods<br/>Transplantation, Autologous--adverse effects